ClinicalTrials.Veeva

Menu

Effect of Intraoperative Nefopam on Acute Pain After Remifentanil Based Anesthesia

H

Hallym University Kangnam Sacred Heart Hospital

Status and phase

Unknown
Phase 4

Conditions

Cholecystitis

Treatments

Drug: Saline
Drug: Ketamine
Drug: Nefopam

Study type

Interventional

Funder types

Other

Identifiers

NCT02493231
2014-10-133

Details and patient eligibility

About

Many anesthesiologists use the Remifentanil for reducing a surgical pain and stabilizing a vital sign. However, this drug induce postoperative hyperalgesia. Nowadays, many studies report that low-dose Ketamine prevents the opioid-induces hyperalgesia. Nefopam,which is non-opioid analgesic, has similar mechanism with Ketamine. It will be helpful for postoperative pain control, and reduce the needs of opioid.

Enrollment

60 estimated patients

Sex

All

Ages

20 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • patient who scheduled laparoscopic cholecystectomy under general anesthesia
  • American Society of Anesthesiologist(ASA) class I or II
  • adult patient (age 20 - 65)

Exclusion criteria

  • patient who has liver disease
  • patient who has kidney disease
  • patient who has diabetes mellitus(DM) or heart disease
  • patient who takes opioid or beta-blocker
  • patient who has airway disease
  • patient who has allergy with the drug

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Single Group Assignment

Masking

Double Blind

60 participants in 3 patient groups, including a placebo group

Nefopam
Active Comparator group
Description:
The generic name is 'ACUPAN'. It is infused during operation. A induction dose is 0.3mg/Kg. A maintenance dose is 65 mcg/kg/hr
Treatment:
Drug: Nefopam
Ketamine
Active Comparator group
Description:
It is infused during operation. A induction dose is 0.3 mg/Kg. A maintenance dose is 3 mcg/kg/hr
Treatment:
Drug: Ketamine
Saline
Placebo Comparator group
Description:
It is infused during operation. A induction volume is 3mL A maintenance dose is 10mL/hr
Treatment:
Drug: Saline

Trial contacts and locations

1

Loading...

Central trial contact

Mi hyun Lee

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems